May 23, 2025 – Moderna Inc. on Friday submitted a marketing application for its updated COVID-19 vaccine, branded as Spikevax to the U.S. Food and Drug Administration (FDA). This updated vaccine targets SARS-CoV-2 variant LP.8.1 of the JN.1 lineage. https://www.coherentmarketinsights.com/news/moderna-files-fda-application-for-updated-covid-vaccine-1265